http://www.stylenc.org
A collaborative between UNC and community-based prevention and case management agencies will conduct and evaluate a social marketing campaign on college campuses, promote access to HIV treatment and care among newly diagnosed African American HIV-infected college students at a consortium of colleges.      

They will assess the prevalence of acute HIV infections through a serosurvey, and compare outcomes between campuses exposed and not exposed to the intervention.

[click here to see Site Presentation given at January 2005 Grantee Meeting]

Intervention

• Elicitation research to develop a prevention intervention 
• Outreach by CBO and campus organization staff to inform about HIV and promote CTR 
• Media campaign on campuses and in local community 
• Social marketing partnerships with campus groups and local businesses, freshman orientation education; CTR at student health centers and in the community 
• Cultural competency training of CTR staff 
• Use of RNA testing in CTR 
• Health department Disease Intervention Specialists to locate HIV+ not in care and promote partner testing 
• Provision of primary and specialty care via UNC ID clinic 
• Prevention for positives program at UNC ID via new protocol follow-up by DIS and local case managers to locate HIV+ lost to care  

Outputs 

• Six focus groups will be held to develop prevention intervention 
• Greater than 85/90% of HIV+ located and linked to care  

Short Term Outcomes

• Increase penetration and receipt of prevention messages 
• Increase use of CTR and knowledge of individual serostatus 
• Decrease risk behaviors by HIV+ and within larger community 
• Increase identification of HIV+ earlier in course of disease and increase access and retention in care 
• Increase quality of primary care and prevention services  

Long Term Outcomes 

• Improve health outcomes and enhanced quality of life for HIV+ patients 
• Decrease morbidity and mortality among HIV+ and decrease HIV transmission within community  

Proposed Local Evaluation Strategy 

• Compare individual at the participating campuses and those at similar non-participating campuses 
• Focus groups and key informant interviews with peers, members of advisory board and staff 
• Interviews pre-test and also end of Years 2 and 5 
• Convenience sampling to assess n=100 general population and n=50 members of target population 
• Seroprevalence study on intervention and control campuses in pooled batches to identify RNA+ samples versus antibody testing, to assess acute infection 
• Linkages into care at UNC ID clinic will be tracked over time, but tools and method based on existing project evaluation (demographic, clinical, behavioral, utilization) at UNC ID clinic